claims:
  - id: c1
    text: "Significant speedups observed in genomic data processing when migrating from manual pipelines to GPU-accelerated workflows on OCI."
    confidence: medium
    source:
      href: "https://docs.oracle.com/en-us/iaas/data-science/using/gpu.htm"
      type: oracle-doc
      date: "2023-12-01"
      notes: "OCI Data Science GPU capabilities documentation"
    qualification: "Results vary by workload, data size, and optimization level."
    risk_level: low

  - id: c2
    text: "Potential TCO reductions through elastic cloud consumption and right-sizing compared to on-premises HPC."
    confidence: medium
    source:
      href: "internal-poc-genetics-2024"
      type: internal-POC
      date: "2024-09-15"
      notes: "Approved internal POC results for external use"
    qualification: "Actual costs depend on utilization patterns and reserved capacity."
    risk_level: low

  - id: c3
    text: "Reference architectures on OCI leverage Generative AI Service and OCI Data Science for genomic analysis solutions."
    confidence: high
    source:
      href: "https://docs.oracle.com/en-us/iaas/GenerativeAI/index.html"
      type: oracle-doc
      date: "2024-06-01"
      notes: "OCI Generative AI Service documentation"
    qualification: "Customers/partners build solutions using these services."
    risk_level: none

  - id: c4
    text: "AI-assisted target identification may improve research efficiency."
    confidence: low
    source:
      href: "https://www.nature.com/articles/s41587-023-01735-6"
      type: peer-reviewed
      date: "2023-04-01"
      notes: "Peer-reviewed study on AI in drug discovery"
    qualification: "Outcomes depend on implementation and context."
    risk_level: medium
